EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
6.3.2.1 | (2-[[(1-benzofuran-2-carbonyl)amino]methyl]-5-methoxy-1H-indol-1-yl)acetic acid | - |
Mycobacterium tuberculosis | |
6.3.2.1 | (2-[[(1-benzofuran-2-sulfonyl)amino]methyl]-5-methoxy-1H-indol-1-yl)acetic acid | - |
Mycobacterium tuberculosis | |
6.3.2.1 | (2-[[(1-benzofuran-2-yl)methoxy]carbonyl]-5-methoxy-1H-indol-1-yl)acetic acid | - |
Mycobacterium tuberculosis | |
6.3.2.1 | (5-methoxy-2-[[2-nitro-4-(trifluoromethyl)benzene-1-sulfonyl]carbamoyl]-1H-indol-1-yl)acetic acid | - |
Mycobacterium tuberculosis | |
6.3.2.1 | (5-methoxy-2-[[4-(trifluoromethyl)benzene-1-sulfonyl]carbamoyl]-1H-indol-1-yl)acetic acid | - |
Mycobacterium tuberculosis | |
6.3.2.1 | additional information | construction of inhibitor molecules with optimized binding efficiencies, the stepwise growing of an indole fragment leads to the generation of a lead compound, analysis of the binding kinetics of the compounds, overview | Mycobacterium tuberculosis | |
6.3.2.1 | [2-[(1-benzofuran-2-sulfonyl)carbamoyl]-5-methoxy-1H-indol-1-yl]acetic acid | - |
Mycobacterium tuberculosis | |
6.3.2.1 | [2-[(4-acetamidobenzene-1-sulfonyl)carbamoyl]-5-methoxy-1H-indol-1-yl]acetic acid | - |
Mycobacterium tuberculosis | |
6.3.2.1 | [2-[(4-acetylpiperazine-1-sulfonyl)carbamoyl]-5-methoxy-1H-indol-1-yl]acetic acid | - |
Mycobacterium tuberculosis | |
6.3.2.1 | [2-[(4-tert-butylbenzene-1-sulfonyl)carbamoyl]-5-methoxy-1H-indol-1-yl]acetic acid | - |
Mycobacterium tuberculosis | |
6.3.2.1 | [2-[(5-acetamido-1,3,4-thiadiazole-2-sulfonyl)carbamoyl]-5-methoxy-1H-indol-1-yl]acetic acid | - |
Mycobacterium tuberculosis | |
6.3.2.1 | [5-methoxy-2-[(4-methoxybenzene-1-sulfonyl)carbamoyl]-1H-indol-1-yl]acetic acid | - |
Mycobacterium tuberculosis | |
6.3.2.1 | [5-methoxy-2-[(4-methylbenzene-1-sulfonyl)carbamoyl]-1H-indol-1-yl]acetic acid | - |
Mycobacterium tuberculosis | |
6.3.2.1 | [5-methoxy-2-[(5-methylpyridine-2-sulfonyl)carbamoyl]-1H-indol-1-yl]acetic acid | - |
Mycobacterium tuberculosis | |
6.3.2.1 | [5-methoxy-2-[(morpholine-4-sulfonyl)carbamoyl]-1H-indol-1-yl]acetic acid | - |
Mycobacterium tuberculosis | |
6.3.2.1 | [5-methoxy-2-[(naphthalene-2-sulfonyl)carbamoyl]-1H-indol-1-yl]acetic acid | - |
Mycobacterium tuberculosis |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
6.3.2.1 | Mg2+ | required | Mycobacterium tuberculosis |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
6.3.2.1 | ATP + (R)-pantoate + beta-alanine | Mycobacterium tuberculosis | - |
AMP + diphosphate + (R)-pantothenate | - |
? | |
6.3.2.1 | ATP + (R)-pantoate + beta-alanine | Mycobacterium tuberculosis ATCC 25618 / H37Rv | - |
AMP + diphosphate + (R)-pantothenate | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
6.3.2.1 | Mycobacterium tuberculosis | P9WIL5 | - |
- |
6.3.2.1 | Mycobacterium tuberculosis ATCC 25618 / H37Rv | P9WIL5 | - |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
6.3.2.1 | ATP + (R)-pantoate + beta-alanine | - |
Mycobacterium tuberculosis | AMP + diphosphate + (R)-pantothenate | - |
? | |
6.3.2.1 | ATP + (R)-pantoate + beta-alanine | - |
Mycobacterium tuberculosis ATCC 25618 / H37Rv | AMP + diphosphate + (R)-pantothenate | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
6.3.2.1 | PanC | - |
Mycobacterium tuberculosis |
6.3.2.1 | Pantothenate synthetase | - |
Mycobacterium tuberculosis |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
6.3.2.1 | ATP | - |
Mycobacterium tuberculosis |
EC Number | General Information | Comment | Organism |
---|---|---|---|
6.3.2.1 | physiological function | pantothenate synthetase catalyzes the ATP-dependent formation of an amide bond between pantoate and beta-alanine | Mycobacterium tuberculosis |